From the Departments of *Nuclear Medicine and †Radiology, Sterling Cancer Hospital, Ahmedabad, Gujarat, India.
Clin Nucl Med. 2017 Nov;42(11):e472-e474. doi: 10.1097/RLU.0000000000001840.
Hepatocellular carcinoma carries a high risk of invasion of the portal vein. Neoplastic and bland portal vein thrombi discrimination is of great clinical significance for determining the therapeutic approach, predicting survival, and assessing candidates for liver transplantation. F-FDG PET/CT may be helpful in discriminating between malignant and portal vein thrombi. We present the case of a 61-year old man who presented with hepatocellular carcinoma with portal vein involvement. F-FDG PET/CT has a role in differentiating malignant from benign portal vein thrombosis.
肝细胞癌有很高的门静脉侵犯风险。肿瘤性和非肿瘤性门静脉血栓的鉴别对于确定治疗方法、预测生存和评估肝移植候选者具有重要的临床意义。^18^F-FDG PET/CT 有助于鉴别恶性与门静脉血栓。我们报告了一例 61 岁男性，患有伴门静脉受累的肝细胞癌。^18^F-FDG PET/CT 可用于鉴别恶性与良性门静脉血栓。
